Ameriprise
YCBD icon

Ameriprise’s cbdMD YCBD Stock Holding History

Ameriprise’s Portfolio YCBD Stock Details YCBD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,538
Closed -$125K – 4061
2022
Q3 		$125K Sell
1,538
-54
-3% -$7.75K ﹤0.01% 3787
2022
Q2 		$252K Sell
1,592
-42
-3% -$9.95K ﹤0.01% 3628
2022
Q1 		$612K Buy
1,634
+682
+72% +$230K ﹤0.01% 3407
2021
Q4 		$370K Buy
952
+103
+12% +$59.9K ﹤0.01% 3611
2021
Q3 		$636K Buy
849
+299
+54% +$250K ﹤0.01% 3323
2021
Q2 		$574K Buy
550
+99
+22% +$118K ﹤0.01% 3405
2021
Q1 		$672K Buy
451
+130
+40% +$189K ﹤0.01% 3299
2020
Q4 		$341K Buy
+321
New +$292K ﹤0.01% 3465

Other funds holding YCBD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MC
Merlin Capital Newport, Rhode Island $33.5M AUM 36.34% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
SL
Sentinus LLC Oak Brook, Illinois $1.25B AUM 22.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CIM
Cambria Investment Management Manhattan Beach, California $2.02B AUM 35.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Ameriprise's YCBD Position: Q4 2022 in Review

Ameriprise sold out of cbdMD (YCBD) in Q4 2022, closing a stake of 1,538 shares — an estimated $125K sold.

Ameriprise first reported a position in YCBD in Q4 2020 and held it in 8 quarters. The position peaked at $672K in Q1 2021. 43 funds tracked by Wall St. Rank hold YCBD as of Q4 2022.

  • Ameriprise reported no remaining cbdMD position as of Q4 2022 after selling out during the quarter.
  • Ameriprise sold 1,538 cbdMD shares in Q4 2022, an estimated $125K.
  • Ameriprise first reported a position in cbdMD in Q4 2020 and held it in 8 quarters.
  • Ameriprise's cbdMD position peaked at $672K in Q1 2021.
  • 43 funds tracked by Wall St. Rank held cbdMD as of Q4 2022.

Based on Ameriprise's 13F filing for Q4 2022, filed 14 Feb 2023.